Cargando…

The Human Milk Oligosaccharides 3‐FL, Lacto‐N‐Neotetraose, and LDFT Attenuate Tumor Necrosis Factor‐α Induced Inflammation in Fetal Intestinal Epithelial Cells In Vitro through Shedding or Interacting with Tumor Necrosis Factor Receptor 1

SCOPE: Human milk oligosaccharides (hMOs) can attenuate inflammation by modulating intestinal epithelial cells, but the mechanisms of action are not well‐understood. Here, the effects of hMOs on tumor necrosis factor‐α (TNF‐α) induced inflammatory events in gut epithelial cells are studied. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Lianghui, Kong, Chunli, Wang, Wenjia, Groeneveld, Andre, Nauta, Arjen, Groves, Matthew R., Kiewiet, Mensiena B. G., de Vos, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047892/ https://www.ncbi.nlm.nih.gov/pubmed/33465830 http://dx.doi.org/10.1002/mnfr.202000425

Ejemplares similares

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
por: Vandenplas, Yvan, et al.
Publicado: (2018)

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition
por: Hegar, Badriul, et al.
Publicado: (2019)

Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infantis Physiology
por: Özcan, Ezgi, et al.
Publicado: (2018)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose
por: Moya-Gonzálvez, Eva M., et al.
Publicado: (2021)

Effects of Different Human Milk Oligosaccharides on Growth of Bifidobacteria in Monoculture and Co-culture With Faecalibacterium prausnitzii
por: Cheng, Lianghui, et al.
Publicado: (2020)

Safety of the extension of use of 2’‐fucosyllactose (2’‐FL) and lacto‐N‐neotetraose (LNnT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

Modular pathway engineering of key precursor supply pathways for lacto-N-neotetraose production in Bacillus subtilis
por: Dong, Xiaomin, et al.
Publicado: (2019)

Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
por: Elison, Emma, et al.
Publicado: (2016)

The in vivo effect of Lacto-N-neotetraose (LNnT) on the expression of type 2 immune response involved genes in the wound healing process
por: Farhadihosseinabadi, Behrouz, et al.
Publicado: (2020)

Goat Milk Yoghurt by Using Lacto-B Culture Modulates the Production of Tumor Necrosis Factor-Alpha and Interleukin-10 in Malnourished Rats
por: Nurliyani,, et al.
Publicado: (2014)

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor
Publicado: (1986)

Modulation of Intestinal Epithelial Glycocalyx Development by Human Milk Oligosaccharides and Non‐Digestible Carbohydrates
por: Kong, Chunli, et al.
Publicado: (2019)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Inflammation, tumor necrosis factor, and toxicology.
por: Luster, M I
Publicado: (1998)

Tumor Necrosis Factor and Regulatory T Cells
por: Jung, Min Kyung, et al.
Publicado: (2019)

Safety of lacto‐N‐neotetraose (LNnT) produced by derivative strains of E. coli BL21 as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2020)

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis
por: Atan, Denize, et al.
Publicado: (2013)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
por: Kitaura, Hideki, et al.
Publicado: (2022)

RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice
por: Zhong, Xue, et al.
Publicado: (2022)

Modulation of Tumor Necrosis Factor by Microbial Pathogens
por: Rahman, Masmudur M, et al.
Publicado: (2006)

Enhancement of experimental metastasis by tumor necrosis factor
Publicado: (1993)

Tumor necrosis factor: is it time to change the name?
por: Pisetsky, David S
Publicado: (2014)

Tumor necrosis factor inhibitors – state of knowledge
por: Lis, Krzysztof, et al.
Publicado: (2014)

Tumor Necrosis Factor Production and Colon Cancer
por: Ito, Hisashi, et al.
Publicado: (1996)

Listeria Cerebritis with Tumor Necrosis Factor Inhibition
por: Reilly, Eileen, et al.
Publicado: (2020)

Tumor necrosis factor as a pharmacological target
por: Ghezzi, Pietro, et al.
Publicado: (2005)

Tumor necrosis factor and interferon: cytokines in harmony
por: Bartee, Eric, et al.
Publicado: (2008)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Tumor Necrosis Factor: What Is in a Name?
por: Wang, Xinming, et al.
Publicado: (2022)

Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2
por: Miao, Kun, et al.
Publicado: (2020)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

Effects of Tumor Necrosis Factor and Hyperthermia on Meth‐A Tumors
por: Hiraoka, Masahiro, et al.
Publicado: (1991)

Glucocorticoid-mediated inhibition of endotoxin-induced intratumor tumor necrosis factor production and tumor hemorrhagic necrosis and regression
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_d3b79hu16lgb2sn1mele3m67n9